Advertisement
COVID-19-related case fatality rates are higher for patients with Parkinson disease

COVID-19 Mortality Higher in Patients With Parkinson Disease

0
Higher case fatality rates found to be independent of demographic factors, such as age, sex, and race
Loss of smell is prevalent among individuals with severe acute respiratory syndrome coronavirus 2 antibodies

Loss of Smell Prevalent in Those With SARS-CoV-2 Antibodies

0
Presence of SARS-CoV-2 antibodies 2.86-fold more likely in those with loss of smell versus loss of taste
The highest daily rate of new COVID-19 cases in the United States in nearly two months was reported late last week.

Daily COVID-19 Cases in U.S. Highest in Months

0
Decline seen in just three states: Texas, Missouri, and South Carolina
Two U.S. researchers and a British scientist have been awarded the 2020 Nobel Prize in physiology or medicine for major contributions to the fight against blood-borne hepatitis.

Three Scientists Share Nobel Prize for Hepatitis C Research

0
Nobel Committee described their work as 'a landmark achievement in our battle against viral infections'
Infection with the new coronavirus can occur through airborne transmission between people farther than 6 feet apart

CDC Now Acknowledges Airborne Transmission of COVID-19

0
Agency says it is especially true in enclosed spaces with inadequate ventilation
Adult patients with current or previous severe acute respiratory syndrome coronavirus 2 can develop a hyperinflammatory syndrome

CDC Reports Cases of Multisystem Inflammatory Syndrome in Adults

0
MIS-A related to SARS-CoV-2 infection resembles MIS in children; respiratory symptoms often minimal
Greater nurse staffing and intensivist hours are associated with significantly lower rates of sepsis

Nursing, Intensivist Staffing Tied to Lower Hospital Sepsis Rates

0
In contrast, greater physician staffing, hospitalist hours associated with higher sepsis rates
Older adults are likely to be excluded from many COVID-19 clinical trials and all vaccine trials

Older Adults Likely to Be Excluded From COVID-19 Trials

0
Fifty percent of phase 3 clinical trials and 100 percent of vaccine trials at risk for excluding older adults
For patients with COVID-19 receiving extracorporeal membrane oxygenation support

Mortality Below 40 Percent for COVID-19 Patients Put on ECMO

0
Cumulative incidence of in-hospital mortality estimated to be 37.4 percent at 90 days
Antibodies decrease with time after COVID-19 symptom onset

Antibodies Decrease With Time After COVID-19 Symptom Onset

0
For all donors of convalescent plasma, drop seen in anti-RBD antibody levels from first to last donation